OKYO Pharma Limited (OKYO)

NASDAQ: OKYO · IEX Real-Time Price · USD
2.20
0.00 (0.00%)
Jul 5, 2022 3:59 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Year 20202019
Selling, General & Admin
3.191.02
Research & Development
0.170.52
Operating Expenses
3.371.53
Operating Income
-3.37-1.53
Interest Expense / Income
00
Other Expense / Income
0.010.08
Pretax Income
-3.38-1.62
Income Tax
-0.02-0.08
Net Income
-3.35-1.54
Net Income Common
-3.35-1.54
Shares Outstanding (Basic)
1,407-
EPS (Basic)
-0.65-
EPS (Diluted)
-0.65-
Free Cash Flow Per Share
-0.07-
Effective Tax Rate
0.74%4.71%
EBITDA
-3.37-1.61
Depreciation & Amortization
0.010.01
EBIT
-3.38-1.62
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).